Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD



Rating:

Share or cite this content

Citations should be made in the following way:
R. Suri (Los Angeles, United States of America), D. Markovic (Los Angeles, United States of America), D. Tashkin (Los Angeles, United States of America), C. Cooper (Los Angeles, United States of America), R. Paine (Salt Lake City, United States of America), A. Freeman (Salt Lake City, United States of America), M. Arjomandi (San Francisco, United States of America), R. Barr (New York City, United States of America), R. Bowler (Denver, United States of America), R. Buhr (Los Angeles, United States of America), J. Curtis (Ann Arbor, United States of America), M. Dransfield (Tuscaloosa, United States of America), M. Drummond (Chappell Hill, United States of America), S. Fortis (Iowa City, United States of America), M. Han (Ann Arbor, United States of America), E. Hoffman (Iowa City, United States of America), V. Kim (Philadelphia, United States of America), W. O'Neal (Chappell Hill, United States of America), V. Ortega (Winston-Salem, United States of America), F. Martinez (New York City, United States of America), S. Rennard (Omaha, United States of America), P. Woodruff (San Francisco, United States of America), I. Barjaktarevic (Los Angeles, United States of America). Altitude effect on COPD in SPIROMICS cohort. 2554

Member's Comments

No comment yet.

Related content which might interest you: Impact of chronic cough in individuals with COPD: a population-based cohort study Source: International Congress 2019 – More and more COPD Year: 2019 The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020 Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Frequency and impact of bronchiectasis in a cohort of patients in a COPD clinic Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study) Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Systemic effects of bronchial colonization in early COPD patients enrolled in the PAC-COPD cohort Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007 The PLATINO cohort study: The natural history of COPD Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study Source: Eur Respir J, 55 (2) 1901335; 10.1183/13993003.01335-2019 Year: 2020 Progression of physical inactivity in COPD patients: the effect of time and climate conditions – a multicentre prospective cohort study Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 Prognosis of COPD according to exacerbation history: a population-based cohort study Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019 Pilot of a population cohort for the study of the natural history of COPD and OSAS: the pulsaib study Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Effects of ambient temperature on COPD symptoms and exacerbations in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS) cohort Source: Virtual Congress 2021 – Environment and respiratory health Year: 2021 A prospective cohort study on the effects of pulmonary rehabilitation on non-COPD lung disease Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients Year: 2007 A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Disease activity in long-term survivors of COPD: 10-years’ follow-up data from the Hokkaido COPD cohort study Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study Source: Eur Respir J 2014; 43: 1289-1297 Year: 2014 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014